Floatz logo

Pegylated Interferon Alpha2A

Hemophilia

Baqiyatallah Medical Sciences UniversityPhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
81/ 100

Competitive context

18 Active assets in the Hemophilia cohort.

Asset / SponsorPhaseRating
Rfviii
Chulalongkorn University
Phase 4BB
Stsp-0601 For
Jiangsu BioJeTay Biotechnology Co., Ltd.
Phase 3BB
IMMUNOGLOBULIN G1, ANTI-(HUMAN TISSUE FACTOR PATHWAY INHIBITOR) (HUMAN MONOCLONAL PF-06741086 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL PF-06741086 .LAMBDA.-CHAIN, DIMER
Institute of Hematology & Blood Diseases Hospital, China
Phase 2BB
Ribavirin
Kenneth Sherman
Phase 4BB
Activated Prothrombin Complex Concentrate
Baxalta now part of Shire
Phase 3BB

View all 32 →

Same molecule, other indications

Pegylated Interferon Alpha2A is also rated in:

hepatitis C virus infectionDormant
A
Indicative ·
81 / 100
View asset →
chronic hepatitis C virus infectionDormant
A
Indicative ·
81 / 100
View asset →
chronic hepatitis B virus infectionDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →